Literature DB >> 18989276

Epstein-Barr virus sustains tumor killers.

Richard J O'Reilly.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18989276     DOI： 10.1038/nm1108-1148

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders.

Authors:  Anna Merlo; Riccardo Turrini; Riccardo Dolcetti; Debora Martorelli; Elena Muraro; Patrizia Comoli; Antonio Rosato
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

2.  Immunotherapy for EBV-associated malignancies.

Authors:  Anna Merlo; Riccardo Turrini; Riccardo Dolcetti; Paola Zanovello; Antonio Rosato
Journal:  Int J Hematol       Date:  2011-02-19       Impact factor: 2.490

3.  A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.

Authors:  Yoonsu Choi; Carrie Yuen; Sourindra N Maiti; Simon Olivares; Hillary Gibbons; Helen Huls; Robert Raphael; Thomas C Killian; Daniel J Stark; Dean A Lee; Hiroki Torikai; Daniel Monticello; Susan S Kelly; Partow Kebriaei; Richard E Champlin; Sibani L Biswal; Laurence J N Cooper
Journal:  Biomed Microdevices       Date:  2010-10       Impact factor: 2.838

Review 4.  Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies.

Authors:  L A Marr; D E Gilham; J D M Campbell; A R Fraser
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.